)
Jennifer Boulton
Jennifer Boulton is a seasoned business development leader with over 28 years of experience in the biopharmaceutical, analytical technology, and CDMO industries. As Senior Director of Business Development at SK pharmteco, she plays a key role in driving strategic partnerships and expanding the company’s global reach in end-to-end cell and gene therapy manufacturing.
Prior to joining SK pharmteco, Jennifer held senior roles at MilliporeSigma, where she led business development initiatives in viral and gene therapy manufacturing, and at SCIEX, where she managed sales growth for automated capillary electrophoresis solutions in the biopharma sector. Her expertise spans contract manufacturing, strategic relationship management, and commercialization of cutting-edge biologics and advanced therapies.
With a track record of fostering key opinion leader engagement and driving innovative solutions in bioprocessing, Jennifer is passionate about advancing transformative therapies that improve patient outcomes.
Based in Thousand Oaks, California, Jennifer continues to be a driving force in the evolution of next-generation therapeutics.